Deargen and KMEDIhub conducted co-developemnt for new drug discovery AI platform.
Read More
Technical & News Articles about Deargen
Deargen and KMEDIhub conducted co-developemnt for new drug discovery AI platform.
Read MoreDeargen announced on 6th that they agreed to collaborate with JW pharmaceutical to develop innovative new drugs via Deargen’s AI model.
Read MoreDeargen has completed the end-to-end AI drug development platform ‘DEARGEN iDeas” to serve as a high-quality data productino for advancing its platform.
Read MoreInhwan Bae, CDO of Deargen, said through the iDear Center that Deargen will enhance the preclinical pipeline and be in full swing of innovative drug development.
Read MoreOne of the most significant business models for AI drug development companies is collaborating with global companies..
Read MoreDeargen starts a research collaboration with NeogenTC to develop a TCR-T treatment prediction platform using Deargen’s sequence-based AI technology.
Read More2022월 03월 24일 디어젠 주식회사 대표이사 강 길 수
Read MoreThe first interview article on Kilsoo Kang, CEO of Deargen, after he successfully secured the SeriesB funding round.
Read MoreDeargen presented a new AI technology on ‘enhanced model on estimating certainty in new drug candidates.’
Read MoreWill establish a 2,600m2 AI convergence new drug development center (iDear Center) and accelerate internal new drug development
Read More